Publication | Closed Access

Cost Effectiveness of Donepezil in the Treatment of Mild to Moderate Alzheimerʼs Disease

Alzheimer's DiseaseGeriatricsMedicineTreatment EvaluationPharmacoeconomicsPharmacotherapyNeurologyAging-associated DiseaseCost EffectivenessPharmacologyTreatmentModerate Alzheimerʼs DiseaseGeriatric Neurology